LFCR

Lifecore Biomedical (LFCR)

Lifecore Biomedical Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:LFCR

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/20	06 : 05	GlobeNewswire Inc.	Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/12/19	21 : 00	GlobeNewswire Inc.	Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/12/11	06 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/12/11	06 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/11/27	07 : 29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/11/27	06 : 05	GlobeNewswire Inc.	Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/11/22	06 : 17	GlobeNewswire Inc.	Lifecore Biomedical Hosts Virtual Investor Day	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/11/21	21 : 55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/11/21	00 : 14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/11/13	06 : 05	GlobeNewswire Inc.	Lifecore Biomedical to Present at Stephens Annual Investment Conference	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/11/13	04 : 43	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/11/09	06 : 32	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/11/07	21 : 00	GlobeNewswire Inc.	Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/11/04	21 : 00	GlobeNewswire Inc.	Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/11/01	05 : 18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/10/30	05 : 46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/10/24	05 : 04	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/10/23	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/10/16	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/10/11	05 : 40	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/10/11	05 : 38	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/10/11	05 : 37	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/10/11	05 : 36	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/10/08	02 : 03	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/10/04	20 : 41	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/10/04	20 : 36	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/10/04	20 : 30	GlobeNewswire Inc.	Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/10/04	20 : 20	GlobeNewswire Inc.	Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/10/04	05 : 05	GlobeNewswire Inc.	Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024	NASDAQ:LFCR	Lifecore Biomedical Inc
2024/10/01	20 : 00	GlobeNewswire Inc.	Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology	NASDAQ:LFCR	Lifecore Biomedical Inc